Scientific Program
GP80 - The Evolving Anti-VEGF Paradigm in India (Novartis)
Date
27/09/2025
Hall
Ball room 1 ( Hall B )
From
11:00
To
12:15
Summary
Moderator: Dr Lalit Verma Panelist: Dr. Tinku Bali Speaker (10 minutes each) - Dr. Gagan Bhatia : Original Ranibizumab: The Gold Standard Anti VEGF - Dr. Indu Singh : Breaking barriers in the management of DME - Vikram Koundanya - Early intensive treatment in nAMD: an overview - Dr. Ramesh Venkatesh : Efficacy vs safety: Striking the right balance in Anti-VEGF therapy Panel Discussion (20 minutes)
Membership No
Name
Topic
Role
Duration
Consented
V02902
Dr.Lalit Verma
Moderator
B08732
Dr.Tinku Bali
Panelist
B12375
Dr.Gagan Bhatia
Original Ranibizumab: The Gold Standard Anti VEGF
Speaker
I25561
Dr.Indu Singh
Breaking barriers in the management of DME
Speaker
V14265
Dr.Ramesh Venkatesh
Efficacy vs safety: Striking the right balance in Anti-VEGF therapy
Speaker
K14848
Dr.Vikram Vinayak Koundanya
Early intensive treatment in nAMD: an overview
Speaker
